Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,660.30 | 22.50 | 0.26% |
CAC 40 | 7,773.93 | 5.79 | -0.07% |
DAX 40 | 24,051.20 | 117.97 | 0.49% |
Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
FTSE 100 | 8,745.93 | 29.48 | 0.34% |
HKSE | 23,289.77 | 283.61 | -1.20% |
NASDAQ | 19,175.87 | 74.93 | 0.39% |
Nikkei 225 | 37,965.10 | 467.88 | -1.22% |
NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
S&P 500 | 5,912.17 | 23.62 | 0.40% |
S&P/ASX 200 | 8,434.70 | 24.90 | 0.30% |
SSE Composite Index | 3,347.49 | 15.96 | -0.47% |